BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10903605)

  • 21. Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
    Demirkaya M; Celebi S; Sevinir B; Hacımustafaoglu M
    Pediatr Hematol Oncol; 2013 Mar; 30(2):141-8. PubMed ID: 23301757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center.
    Siami FS; LaFleur BJ; Siami GA
    Clin Ther; 2002 Jan; 24(1):59-72. PubMed ID: 11833836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of a prospective, randomized, double blind comparison of the efficacy and the safety of sequential ciprofloxacin (intravenous/oral)+metronidazole (intravenous/oral) with ceftriaxone (intravenous)+metronidazole (intravenous/oral) for the treatment of intra-abdominal infections.
    Starakis I; Karravias D; Asimakopoulos C; Kolaras P; Nikolaidis P; Harlaftis N; Skoutelis A; Bassaris H
    Int J Antimicrob Agents; 2003 Jan; 21(1):49-57. PubMed ID: 12507837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotics as first-line therapy for acute appendicitis: evidence for a change in clinical practice.
    Andersson RE; Schein M
    World J Surg; 2012 Sep; 36(9):2037-8. PubMed ID: 22638683
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
    Prabhu V; Foo J; Ahir H; Sarpong E; Merchant S
    J Med Econ; 2017 Aug; 20(8):840-849. PubMed ID: 28532194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
    Ohlin B; Cederberg A; Forssell H; Solhaug JH; Tveit E
    Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam.
    Cormio L; Berardi B; Callea A; Fiorentino N; Sblendorio D; Zizzi V; Traficante A
    BJU Int; 2002 Nov; 90(7):700-2. PubMed ID: 12410751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults.
    Yellin AE; Hassett JM; Fernandez A; Geib J; Adeyi B; Woods GL; Teppler H;
    Int J Antimicrob Agents; 2002 Sep; 20(3):165-73. PubMed ID: 12385694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
    Karaman S; Vural S; Yildirmak Y; Emecen M; Erdem E; Kebudi R
    Pediatr Blood Cancer; 2012 Apr; 58(4):579-83. PubMed ID: 21674768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Initial empirical antimicrobial therapy with piperacillin/tazobactam in intra-abdominal infections due to perforation of the large intestine and rectum and in postoperative complications after resection of the large intestine and rectum].
    Vyhnánek F; Faltýn J; Lochmann O
    Rozhl Chir; 2002 Dec; 81(12):617-21. PubMed ID: 12666475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
    Cornely OA; Wicke T; Seifert H; Bethe U; Schwonzen M; Reichert D; Ullmann AJ; Karthaus M; Breuer K; Salzberger B; Diehl V; Fätkenheuer G
    Int J Hematol; 2004 Jan; 79(1):74-8. PubMed ID: 14979482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam.
    Teppler H; Meibohm AR; Woods GL
    J Chemother; 2004 Feb; 16(1):62-9. PubMed ID: 15078001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with the use of piperacillin-tazobactam in pediatric non-renal solid organ transplantation.
    Wiesmayr S; Stelzmueller I; Mark W; Muehlmann G; Tabarelli W; Tabarelli D; Laesser R; Antretter H; Ladurner R; Zimmerhackl LB; Margreiter R; Guggenbichler JP; Bonatti H
    Pediatr Transplant; 2007 Feb; 11(1):38-48. PubMed ID: 17239122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical evaluation of efficacy and safety of cefepime monotherapy versus piperacillin-tazobactam in patients of paediatric age group with febrile neutropenia in a tertiary care centre of north India.
    Aamir M; Abrol P; Sharma D; Punia H
    Trop Doct; 2016 Jul; 46(3):142-8. PubMed ID: 26612093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of a Piperacillin/Tazobactam Shortage on Antimicrobial Prescribing and Clostridium difficile Risk in 88 US Medical Centers.
    Gross AE; Johannes RS; Gupta V; Tabak YP; Srinivasan A; Bleasdale SC
    Clin Infect Dis; 2017 Aug; 65(4):613-618. PubMed ID: 28444166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
    Lipsky BA; Giordano P; Choudhri S; Song J
    J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study.
    Uygun V; Karasu GT; Ogunc D; Yesilipek A; Hazar V
    Pediatr Blood Cancer; 2009 Oct; 53(4):610-4. PubMed ID: 19484759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Controlled, open, parallel-group study of the clinical and microbiological efficacy of piperacillin-tazobactam versus metronidazole + gentamicin in urgent colorectal surgery].
    Ferrer J; Fondevila C; Bombuy E; Fuster J; Alvarez G; Charco R; García-Valdecasas JC
    Cir Esp; 2006 Jun; 79(6):365-9. PubMed ID: 16769001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection.
    DeRyke CA; Kuti JL; Mansfield D; Dana A; Nicolau DP
    Am J Health Syst Pharm; 2006 Apr; 63(8):750-5. PubMed ID: 16595817
    [No Abstract]   [Full Text] [Related]  

  • 40. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.